Ventura BioMed Investors
VC Fund
Ventura BioMed Investors is a VC fund focused on Biotechnology and Medical. Ventura BioMed Investors invest in early-stage life science companies developing pioneering technologies and innovative therapies. As serial entrepreneurs with many years of experience, we help shape the long-term development of our portfolio companies and provide them access to our broad investor and business network. Ventura supports exceptionalentrepreneurs with their vision to accelerate medical breakthroughs that solve unmet patient needs.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Ventura BioMed Investors invests in
Stages Ventura BioMed Investors invests in
Countries Ventura BioMed Investors invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andreas Jenne
|
|||
Investment Focus
Industry
- Biotechnology 6 (67%)
- Medical 2 (22%)
- Health Care 2 (22%)
- Life Science 2 (22%)
- Therapeutics 2 (22%)
Stage
- Seed 4 (44%)
- Series A 2 (22%)
- Venture - Series Unknown 1 (11%)
Country
- Germany 3 (33%)
- Switzerland 2 (22%)
- United States 1 (11%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Andreas Jenne
CEO
|
CEO | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Kupando
|
Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity. | $11.5M / Series A / Mar 18, 2026 | |
arcoris bio
|
arcoris bio provides spatial multiomics solutions focused on transforming biomedical research and diagnostics through innovative and accessible technologies. | $7.8M / Seed / Nov 06, 2025 | |
IRUBIS
|
Irubis provides real-time and online monitoring services. The company develops a silicon crystal for infrared spectroscopy. It is a single-reflection crystal that includes basic single-reflection, low penetration depth, and signal-enhanced ATR crystals. Irubis aims to advance spectroscopy to become the industry standard for real-time bioprocessmonitoring. | Seed / Aug 29, 2024 | |
iQure Pharma
|
iQure Pharma is a global biotech company created by entrepreneurs and former pharma managers that focuses on the development of new therapeutics. | $1.2M / Venture - Series Unknown / Oct 11, 2023 | |
Nia Health
|
Based on its innovative MedTech platform for personalised patient support, Nia Health develops medical software. Nia Health’s end-to-end solutions are indication-specific and tailored to the individual needs of each patient.Nia Health covers a wide variety of use cases in the dermatology and allergology space. Nia Health’s Digital Therapeutics(DTx) combine strong clinical validation with empowerment, gamification and machine learning.It is Nia Health’s mission to provide a highly engaging and personalized patient experience that removes barriers to health behavior change. | $3.8M / Seed / May 15, 2023 | |
Navignostics
|
Our mission is to identify the ideal treatment to battle each cancer patient’s disease and reduce suffering throughout their journey.At Navignostics we characterize tumors using spatial single-cell proteomics. We use our unique capabilities to identify a cancer treatment that will optimally fight each patient’s tumor. We also accelerate cancerdrug development by providing key insights into drug mechanisms and tumor features for companion diagnostic development.Our highly robust and reliable technology and our leading data analytics position us ideally to enable precision cancer diagnostics for patients and to provide services to pharma and biotech partners.This way we help people suffering from cancer by making more drugs available and by finding the right one for every patient. | $7.6M / Seed / Nov 09, 2022 | |
|
IRUBIS
|
Irubis provides real-time and online monitoring services. The company develops a silicon crystal for infrared spectroscopy. It is a single-reflection crystal that includes basic single-reflection, low penetration depth, and signal-enhanced ATR crystals. Irubis aims to advance spectroscopy to become the industry standard for real-time bioprocessmonitoring. | $2.7M / Seed / Oct 06, 2022 | |
|
Kupando
|
Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity. | $12.5M / Series A / Sep 26, 2022 | |
Abalos Therapeutics
|
The company intends to use the funds to advance its arenavirus-based lead candidates towards clinical testing. They will develop the initial product candidates using its proprietary Fast Evolution platform, which will generate virus strains with optimized anti-tumoral properties. These candidates will be selected based on their ability tore-program the immune system to specifically and efficiently eliminate the malignant tumor tissue. | $35.9M / Series A / Oct 14, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ventura BioMed Investors invest in?
Ventura BioMed Investors invests primarily in Biotechnology, Medical and Health Care startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ventura BioMed Investors?
Public channels for Ventura BioMed Investors include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ventura BioMed Investors?
The team at Ventura BioMed Investors includes Andreas Jenne (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
